Company: IQVIA, Durham, NC
Nomination Submitted by: 10Fold Communications
Company Description: IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. With 82,000 employees, IQVIA conducts operations in over 100 countries.
Nomination Category: Individual Awards Categories
Nomination Sub Category: Most Innovative Woman of the Year - Healthcare
 Nomination Title: Dr. Harietta Eleftherochorinou Meng MSc Ph.D
- Outline the nominee's achievements since July 1 2020 that you wish to bring to the judges' attention (up to 250 words):
Total 247 words used.
Harietta’s background of merging AI, medicine, entrepreneurism and technology led her to create a new IQVIA business division, the Innovation Hub. The new organization manages globally the IQVIA capital, which is being invested in forward-thinking start-ups, and has carved out a new strategy for IQVIA start-up partnerships to transform healthcare. This appointment succeeds her success of building a venture/start-up within IQVIA, which she grew successfully [REDACTED FOR PUBLICATION] exceeding all strategic, financial and operational goals.
The IQVIA Innovation Hub, was launched in June 2021. Harietta reported for 6 months into the Office of the CEO, chosen for her integrity and leadership to lead successfully from concept to implementation, receiving top executive guidance.
In the first six months in operation, the Hub engaged with 500+ start-ups, launched a physical workspace in Israel, rolled out a novel global legal agreement to enable a collaborative framework between the corporation and early-stage companies. As a result, IQVIA developed [REDACTED FOR PUBLICATION] several new partnerships with innovative start-ups, co-creating together transformative healthcare solutions. Most recently, Harietta launched the first ever Innovation Accelerator Program in Israel. As a result of her efforts, there are currently IQVIA innovation initiatives in 14 European countries, US and Asia, [REDACTED FOR PUBLICATION] since launch with novel operations to enable innovation and ultimately new culture. An effective change agent, Harietta’s effort supports the solutions that will truly solve for critical patient unmet needs and advance entrepreneurship and innovation in the healthcare market.
- Reference any attachments of supporting materials throughout this nomination and how they provide evidence of the claims you have made in this nomination (up to 250 words):
Total 99 words used.
- Briefly describe the nominated individual: history and past performance (up to 200 words):
Total 199 words used.
Harietta is the Vice President of Innovation Ventures at IQVIA, an S&P 500 company with 82,000 employees and operations in 100+ countries. She leads the global portfolio of investments and strategic partnerships with start-ups to transform healthcare. Previously, she served as the CEO of an IQVIA venture, [REDACTED FOR PUBLICATION], and was rated as a top performer in four consecutive years. She was the Head of Data Science and Advanced Analytics in Deloitte UK.
Her work has been recognized with multiple awards, including the Fortune 40under40 (2022), Top 25 Women Leaders in UK Healthcare (2019) as an AI Pioneer, the Deloitte Outstanding Achievement for Client Service (2018), the UK Cloud Award of the Year on Innovation (2016) in Analytics, and the prestigious European Union and Welcome Trust funding for research on genomics (2007-2014).
Harietta is an AI pioneer with 20 years of experience in implementing large-scale AI solutions for health. She is a Women in STEM ambassador and mentor to the next generation. An electrical and computer engineer, she holds an MSc in Bioinformatics and PhD in Medicine from Imperial College London. She is of Greek British origin.
- Which will you submit for your nomination in this category, a video of up to five (5) minutes, explaining the achievements since July 1, 2020 of the nominated woman, OR written answers to the questions? (Choose one):
Written answers to the questions
- If you are submitting a video of up to five (5) minutes in length, provide the URL of the video here, OR attach it to your entry via the "Add Attachments, Videos, or Links to This Entry" link above, through which you may also upload a copy of your video. If you are submitting written answers to the questions for this category, provide them in the spaces below:
- Explain why the achievements you have highlighted are unique or significant. If possible compare the achievements to the performance of other players in your industry and/or to the nominee's past performance (up to 250 words):
Total 250 words used.
Capital investments of $100+ billion occurred in 2021 in healthcare start-ups alone. There is an innovation ecosystem taking shape globally with 40,000+ healthcare start-ups, developing transformative solutions and in need of partnering with established firms to take those solutions to market.
Corporate innovation hubs navigate this startup market on behalf of complex multinational corporations to drive investments and develop partnerships. Founding and leading such an organization is far from easy. Several factors come into play, including managing the corporate asset portfolio that is often competitive to that of emerging start-ups; securing available capital with shareholder commitment; creating a two-speed system between large slower corporations and fast-paced start-ups; building a two-culture dynamic of corporate vs entrepreneurial approach; managing different appetites for risk-taking and more that make a corporation-start-up marriage troublesome.
Harietta’s achievements in the first year are impressive, especially when compared to similar industry trajectories that typically dedicate the first year for design alone. Harietta has been ultra-effective in delivering tangible results and fully operationalizing the organization in 6 months. She launched a physical Israeli Innovation Hub and an Accelerator Program; developed processes to identify IQVIA fit-for-purpose start-up partners across Europe, US, and Asia [REDACTED FOR PUBLICATION]. Being creative, she rolled out legal and evaluation processes and a novel creative partnership framework to cater to the diversity of early-stage companies. The future of healthcare is bright from Harietta’s vision of larger corporations joining with start-ups to bring the next generation of medicines and solutions to market, all with the patient at the center.
| Attachments/Videos/Links: |
|---|
|
